IMCRC industry partner Stryker to launch new Australian R&D facility


3D printed bone implant, Source: RMIT

IMCRC congratulates its industry partner Stryker, a global medical technology organisation, on establishing its first Australian research and development (R&D) facility in Queensland, in partnership with the Queensland Government.

With the University of Queensland (UQ) and Queensland University of Technology (QUT) on board, the facility will bring together researchers, clinicians and advanced manufacturers to accelerate Stryker’s R&D initiatives in Australia.

IMCRC has been collaborating with Stryker since 2017, co-investing in an $18 million Australian medtech manufacturing research project that is set to transform the way physicians surgically treat tumours and bone cancer. The five-year R&D collaboration between Stryker, IMCRC and five of Australia’s leading research organisations – RMIT University, the University of Technology Sydney (UTS), University of Sydney, University of Melbourne and St Vincent’s Hospital Melbourne – has incorporated 3D printing, robotic surgery, design and advanced manufacturing. The success of the project has catalysed further investment by Stryker in Australia, including for this new R&D facility.

CEO and Managing Director of IMCRC, David Chuter, congratulated Stryker on demonstrating strong industry leadership with this investment, and said the new facility represented the right framework for collaboration, industry growth and transformation in Australia.

“IMCRC’s business model focuses on facilitating effective industry-led research collaboration by safeguarding investment, nurturing unique talent and translating technical know-how into commercial and globally relevant products, services and processes,” he said.